Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Welch

Showing results (81-90 of 855) with videos related to

Pageof 86
Sort By:
BMJ (Clinical Research Ed.)|March 14, 2012
Healthier ageingPhyo Kyaw Myint, Ailsa A Welch
Infection and Immunity|June 1, 1997
Pleiotropic effects of a mutation in rfaC on Escherichia coli hemolysinM E Bauer, R A Welch
Methods in Enzymology|January 1, 1994
Identification and assay of RTX family of cytolysinsA L Lobo, R A Welch
Future Oncology (London, England)|June 6, 2007
Erlotinib: success of a molecularly targeted agent for the treatment of advanced pancreatic cancerStephen A Welch, Malcolm J Moore
Infection and Immunity|June 1, 1990
The HpmA hemolysin is more common than HlyA among Proteus isolatesK G Swihart, R A Welch
Journal of Bacteriology|March 1, 1990
Nucleotide sequencing of the Proteus mirabilis calcium-independent hemolysin genes (hpmA and hpmB) reveals sequence similarity with the Serratia marcescens hemolysin genes (shlA and shlB)T S Uphoff, R A Welch
Journal of Bacteriology|September 6, 2006
DsdX is the second D-serine transporter in uropathogenic Escherichia coli clinical isolate CFT073Andrew T Anfora, Rodney A Welch
Convulsive Therapy|January 1, 1989
Cardiovascular Effects of ECTCharles A. Welch, Lambertus J. Drop
Arzneimittel-Forschung|August 1, 1994
Health implications of fatty acidsJ T Borlak, V A Welch
Clinical Medicine (London, England)|February 14, 2018
When psychiatric symptoms reflect medical conditionsKillian A Welch, Alan J Carson
Pageof 86

Showing results (81-90 of 855) with videos related to

Sort By:
Pageof 86
BMJ (Clinical Research Ed.)|March 14, 2012
Healthier ageingPhyo Kyaw Myint, Ailsa A Welch
Infection and Immunity|June 1, 1997
Pleiotropic effects of a mutation in rfaC on Escherichia coli hemolysinM E Bauer, R A Welch
Methods in Enzymology|January 1, 1994
Identification and assay of RTX family of cytolysinsA L Lobo, R A Welch
Future Oncology (London, England)|June 6, 2007
Erlotinib: success of a molecularly targeted agent for the treatment of advanced pancreatic cancerStephen A Welch, Malcolm J Moore
Infection and Immunity|June 1, 1990
The HpmA hemolysin is more common than HlyA among Proteus isolatesK G Swihart, R A Welch
Journal of Bacteriology|March 1, 1990
Nucleotide sequencing of the Proteus mirabilis calcium-independent hemolysin genes (hpmA and hpmB) reveals sequence similarity with the Serratia marcescens hemolysin genes (shlA and shlB)T S Uphoff, R A Welch
Journal of Bacteriology|September 6, 2006
DsdX is the second D-serine transporter in uropathogenic Escherichia coli clinical isolate CFT073Andrew T Anfora, Rodney A Welch
Convulsive Therapy|January 1, 1989
Cardiovascular Effects of ECTCharles A. Welch, Lambertus J. Drop
Arzneimittel-Forschung|August 1, 1994
Health implications of fatty acidsJ T Borlak, V A Welch
Clinical Medicine (London, England)|February 14, 2018
When psychiatric symptoms reflect medical conditionsKillian A Welch, Alan J Carson
Pageof 86